Medicare Part D coverage · 0.375 · RxCUI 2720348
0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty]
Per the CMS 2026 Part D formulary file, 0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty] is covered by 143 Medicare Part D plans (2.8% of enrollable products), averaging Tier 4.6, with prior authorization required on 57.1% of covering formularies.
- 2.8%
- Plan coverage
- 143
- Plans covering
- T4.6
- Avg tier
- 57.1%
- Prior auth required
What the CMS Formulary Data Shows for 0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty]
Per the CMS 2026 Part D formulary file, 0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty] (RxNorm concept RXCUI 2720348, generic name 0.375) appears on 7 distinct formulary files spanning 143 Medicare Part D plan offerings - 2.8% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 3 to Tier 5, with a cross-plan average of Tier 4.6.
Real-world access to 0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty] depends on utilization management as much as tier placement: 57.1% of covering formularies require prior authorization. 0% require step therapy. 14.3% apply quantity limits.
Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty] today.
Coverage Details
- Formularies covering
- 7
- Plans covering
- 143
- Coverage rate
- 2.8%
- Tier range
- Tier 3 – Tier 5
- Average tier
- Tier 5, Specialty
Restrictions
- Prior authorization required
- 57.1% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 14.3% of formularies
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Leon MediExtra (HMO) | Leon Health, Inc. | T3 | Yes | $0 | FL |
| Leon MediDual (HMO D-SNP) | Leon Health, Inc. | T3 | Yes | $0 | FL |
| Leon MediMore (HMO) | Leon Health, Inc. | T3 | Yes | $0 | FL |
| Leon MediMax (HMO D-SNP) | Leon Health, Inc. | T3 | Yes | $0 | FL |
| Aspire Health Protect (HMO) | Aspire Health Plan | T4 | Yes | $0 | CA |
| Aspire Health Value (HMO) | Aspire Health Plan | T4 | Yes | $22.60 | CA |
| Aspire Health Advantage (HMO) | Aspire Health Plan | T4 | Yes | $44.80 | CA |
| Aspire Health Plus (HMO-POS) | Aspire Health Plan | T4 | Yes | $119.20 | CA |
| HAP Medicare Explore (PPO) | Alliance Health AND Life Insurance Company | T5 | Yes | $0 | MI |
| HAP Medicare Prime (PPO) | Alliance Health AND Life Insurance Company | T5 | Yes | $0 | MI |
| HAP Medicare Connect (HMO) | Health Alliance Plan OF Michigan | T5 | Yes | $0 | MI |
| HAP Medicare Complete Duals (HMO D-SNP) | Health Alliance Plan OF Michigan | T5 | Yes | $0 | MI |
| HAP Medicare Superior (HMO) | Health Alliance Plan OF Michigan | T5 | Yes | $0 | MI |
| Henry Ford Select (HMO) | Health Alliance Plan OF Michigan | T5 | Yes | $0 | MI |
| Health New England Medicare Compass (PPO) | Health NEW England, Inc. | T5 | Yes | $0 | MA |
| Health New England Medicare Value (HMO) | Health NEW England, Inc. | T5 | Yes | $0 | MA |
| Presbyterian Senior Care Plan 2 with Rx (HMO) | Presbyterian Health Plan | T5 | No | $0 | NM |
| Presbyterian Dual Plus (HMO D-SNP) | Presbyterian Health Plan | T5 | No | $0 | NM |
| Presbyterian Senior Care Extra Health Plan with Rx (HMO) | Presbyterian Health Plan | T5 | No | $0 | NM |
| Kaiser Permanente Senior Advantage LA, Orange Co. (HMO) | Kaiser Foundation HP, Inc. | T5 | No | $0 | CA |
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is 0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty] covered by Medicare Part D?
Yes, 0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty] is covered by 143 Medicare Part D plans (2.8% of all Part D formularies).
What tier is 0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty] on Medicare Part D plans?
0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty] averages Tier 4.6 across Part D plans, ranging from Tier 3 to Tier 5.
Does 0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty] require prior authorization?
57.1% of Part D formularies require prior authorization for 0.375 ML leuprolide acetate 120 MG/ML Prefilled Syringe [Vabrinty]. Step therapy: 0%. Quantity limits: 14.3%.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- 12 HR treprostinil 0.25 MG Extended Release Oral Tablet [Orenitram] T4.6
- paromomycin 250 MG Oral Capsule [Humatin] T4.6
- omaveloxolone 50 MG Oral Capsule [Skyclarys] T4.6
- 0.68 ML vedolizumab 159 MG/ML Auto-Injector [Entyvio] T4.6
- 0.5 ML leuprolide acetate 60 MG/ML Prefilled Syringe [Vabrinty] T4.6
- sirolimus 0.002 MG/MG Topical Gel [Hyftor] T4.6
Similar prior-authorization rate
- clobazam 10 MG Oral Tablet 57.3% PA
- clobazam 20 MG Oral Tablet 57.3% PA
- bempedoic acid 180 MG Oral Tablet [Nexletol] 57.4% PA
- hydroxyzine hydrochloride 25 MG Oral Tablet 56.7% PA
- hydroxyzine hydrochloride 50 MG Oral Tablet 56.7% PA
- memantine hydrochloride 2 MG/ML Oral Solution 56.7% PA